C1QL1 and aortic atherosclerosis: Ad-C1QL1-injected mice and their (Ad-GFP-injected) control counterparts after 12 weeks with the intention of answering two main questions: (1) Does C1QL1 injection through the tail vein affect aortic atherosclerosis and plasma lipids?